ABSTRACT
Thiamine deficiency disorders are an under-recognized public health problem in low- and middle-income countries. Infantile beriberi, the most important symptom for children, is suspected to significantly contribute to infant mortality and lifelong neurodevelopmental morbidity. Lack of awareness, varied clinical presentation, and lack of a readily available diagnostic marker lead to frequent misdiagnoses. We report six thriving infants who presented with an acute fulminant illness with varied clinical manifestations mimicking common childhood illnesses like pneumonia and sepsis. Four of them presented with the severe cardiovascular form, called Shoshin beriberi, and severe pulmonary arterial hypertension. Empirical intravenous thiamine administered to four of the six infants resulted in dramatic recovery. Awareness of the clinical definition of infantile beriberi and treatment with empirical thiamine can be lifesaving.
Subject(s)
Beriberi/complications , Beriberi/diagnosis , Thiamine Deficiency/complications , Beriberi/drug therapy , Beriberi/physiopathology , Fatal Outcome , Female , Humans , Infant , Male , Thiamine/administration & dosage , Thiamine/therapeutic use , Thiamine Deficiency/physiopathology , Treatment OutcomeABSTRACT
BACKGROUND: Few studies have investigated differences in the vulnerabilities of males and females to alcohol use disorder and alcohol-related brain damage (ARBD). According to epidemiological and clinical findings, females appear to be more sensitive to the effects of alcohol and thiamine deficiency and have a worse prognosis in recovery from neurocognitive deficits compared with males. This study aimed to characterize the effects of chronic ethanol (EtOH) toxicity and thiamine deficiency across the sexes using rodent models. METHODS: Male and female Sprague Dawley rats were assigned to chronic forced EtOH treatment (CET), pyrithiamine-induced thiamine deficiency (PTD), combined CET-PTD, or pair-fed (PF) control treatment conditions. Following treatments, spatial working memory was assessed during a spontaneous alternation task while measuring acetylcholine (ACh) in the prefrontal cortex (PFC) and the hippocampus (HPC). The animals also underwent an operant-based attentional set-shifting task (ASST) for the analysis of behavioral flexibility. RESULTS: Female and male rats did not differ in terms of EtOH consumption; however, the CET and CET-PTD-treated female rats had lower BECs than male rats. Compared with the PF group, the CET, PTD, and CET-PTD groups exhibited spatial working memory impairments with corresponding reductions in ACh efflux in the PFC and HPC. The ASST revealed that CET-PTD-treated males and females displayed impairments marked by increased latency to make decisions. Thalamic shrinkage was prominent only in the CET-PTD and PTD treatment conditions, but no sex-specific effects were observed. CONCLUSIONS: Although the CET and CET-PTD-treated females had lower BECs than the males, they demonstrated similar cognitive impairments. These results provide evidence that female rats experience behavioral and neurochemical disruptions at lower levels of alcohol exposure than males and that chronic EtOH and thiamine deficiencies produce a unique behavioral profile.
Subject(s)
Acetylcholine/metabolism , Alcoholism/metabolism , Central Nervous System Depressants/pharmacology , Ethanol/pharmacology , Hippocampus/drug effects , Prefrontal Cortex/drug effects , Thiamine Deficiency/metabolism , Alcoholism/complications , Alcoholism/physiopathology , Animals , Antimetabolites/toxicity , Attention/drug effects , Behavior, Animal/drug effects , Case-Control Studies , Female , Hippocampus/metabolism , Male , Microdialysis , Prefrontal Cortex/metabolism , Pyrithiamine/toxicity , Rats , Sex Factors , Thiamine Deficiency/chemically induced , Thiamine Deficiency/complications , Thiamine Deficiency/physiopathologyABSTRACT
Thiamine deficiency is associated with cerebellar dysfunction; however, the consequences of thiamine deficiency on the electrophysiological properties of cerebellar Purkinje cells are poorly understood. Here, we evaluated these parameters in brain slices containing cerebellar vermis. Adult mice were maintained for 12-13 days on a thiamine-free diet coupled with daily injections of pyrithiamine, an inhibitor of thiamine phosphorylation. Morphological analysis revealed a 20% reduction in Purkinje cell and nuclear volume in thiamine-deficient animals compared to feeding-matched controls, with no reduction in cell count. Under whole-cell current clamp, thiamine-deficient Purkinje cells required significantly less current injection to fire an action potential. This reduction in rheobase was not due to a change in voltage threshold. Rather, thiamine-deficient neurons presented significantly higher input resistance specifically in the voltage range just below threshold, which increases their sensitivity to current at these critical membrane potentials. In addition, thiamine deficiency caused a significant decrease in the amplitude of the action potential afterhyperpolarization, broadened the action potential, and decreased the current threshold for depolarization block. When thiamine-deficient animals were allowed to recover for 1 week on a normal diet, rheobase, threshold, action potential half-width, and depolarization block threshold were no longer different from controls. We conclude that thiamine deficiency causes significant but reversible changes to the electrophysiology properties of Purkinje cells prior to pathological morphological alterations or cell loss. Thus, the data obtained in the present study indicate that increased excitability of Purkinje cells may represent a leading indicator of cerebellar dysfunction caused by lack of thiamine.
Subject(s)
Purkinje Cells/pathology , Thiamine Deficiency/pathology , Thiamine Deficiency/physiopathology , Action Potentials/physiology , Animals , Male , Mice , Mice, Inbred C57BL , Organ Culture Techniques , Patch-Clamp TechniquesABSTRACT
Thiamine-responsive megaloblastic anaemia (TRMA) is a syndrome associated with megaloblastic anaemia, diabetes mellitus and sensorineural deafness, due to mutations in the SLC19A2gene, which codes for a thiamine carrier protein. Oral thiamine supplementation is the main treatment. We report the case of a 19-year-old man known for TRMA, who presented in the emergency department with bicytopenia (haemoglobin 5,4 g/dL, thrombocytes 38×109/L) revealed by dyspnea and chest pain. Investigations excluded bleeding, hemolysis, coagulopathy and iron deficiencies. A recent infection and an acute coronary syndrome have also been eliminated. We later found out that thiamine treatment had been discontinued three months before, due to general confinement in Tunisia during the COVID-19 pandemic. Parenteral administration of 100 mg of thiamine daily resulted in the recovery of haematopoiesis within three weeks.
Subject(s)
Anemia, Megaloblastic/blood , Betacoronavirus , Coronavirus Infections/epidemiology , Diabetes Mellitus/blood , Hearing Loss, Sensorineural/blood , Pandemics , Pneumonia, Viral/epidemiology , Thiamine Deficiency/congenital , Thrombocytopenia/etiology , Acute Coronary Syndrome/diagnosis , Anemia, Megaloblastic/drug therapy , Anemia, Megaloblastic/physiopathology , COVID-19 , Chest Pain/etiology , Diabetes Mellitus/drug therapy , Diabetes Mellitus/physiopathology , Diagnosis, Differential , Glycated Hemoglobin/analysis , Health Services Accessibility , Hearing Loss, Sensorineural/drug therapy , Hearing Loss, Sensorineural/physiopathology , Hemoglobins/analysis , Humans , Male , Pericardial Effusion/diagnostic imaging , Pericardial Effusion/etiology , Recurrence , SARS-CoV-2 , Thiamine/supply & distribution , Thiamine/therapeutic use , Thiamine Deficiency/blood , Thiamine Deficiency/drug therapy , Thiamine Deficiency/physiopathology , Tunisia , Young AdultABSTRACT
OBJECTIVES: The symptoms of thiamine deficiency vary considerably and asymptomatic cases; i.e., subclinical thiamine deficiency (SCTD), are known to exist. However, there is no information available on the treatment of SCTD. METHODS: We report a patient who underwent intravenous thiamine replacement therapy for about a month after being diagnosed with SCTD, but who developed SCTD again about three weeks after finishing the treatment. RESULTS: The patient was a 64-year-old woman who, after starting treatment for cervical cancer, complained of anxiety and underwent an initial psychiatric examination. The psychiatric diagnosis was an adjustment disorder. Based on the possibility of SCTD complications due to her decreased appetite and weight loss, her serum thiamine concentration was measured and found to be low. Therefore, thiamine was administered intravenously for 29 days. At the end of treatment, thiamine administration was discontinued as there were no apparent neuropsychiatric symptoms or problems with appetite. Twenty-three days later, there were still no problems with appetite or neuropsychiatric symptoms, but a follow-up blood sample revealed that her serum thiamine was again below the normal range. SIGNIFICANCE OF RESULTS: Currently, there is no information available regarding the diagnosis and treatment of SCTD in cancer patients. In some cases, such as this case, the deficiency recurs without any symptoms indicative of SCTD; therefore, further examination for diagnosis and treatment is necessary.
Subject(s)
Thiamine Deficiency/diagnosis , Thiamine Deficiency/therapy , Uterine Cervical Neoplasms/complications , Drug Therapy/methods , Female , Humans , Middle Aged , Thiamine/therapeutic use , Thiamine Deficiency/physiopathology , Uterine Cervical Neoplasms/therapySubject(s)
Gastric Bypass , Postoperative Complications/diagnosis , Thiamine Deficiency/diagnosis , Thiamine/therapeutic use , Vitamin B Complex/therapeutic use , Wernicke Encephalopathy/diagnosis , Adult , Bariatric Surgery , Female , Humans , Postoperative Complications/drug therapy , Postoperative Complications/physiopathology , Thiamine Deficiency/drug therapy , Thiamine Deficiency/physiopathology , Treatment Outcome , Wernicke Encephalopathy/drug therapy , Wernicke Encephalopathy/physiopathologyABSTRACT
We herein report a patient with Wernicke-Korsakoff syndrome (WKS) who had neither a history of alcoholism or of history of gastric surgery. A 56-year-old woman was transferred to our hospital because of the loss of consciousness and she was diagnosed to have Wernicke encephalopathy. She showed proton pump inhibitor-induced refractory hypergastrinemia with the subsequent development of hyperemesis and a vitamin B1 deficiency.
Subject(s)
Korsakoff Syndrome/chemically induced , Korsakoff Syndrome/physiopathology , Peptic Ulcer/drug therapy , Proton Pump Inhibitors/adverse effects , Thiamine Deficiency/chemically induced , Thiamine Deficiency/physiopathology , Wernicke Encephalopathy/chemically induced , Wernicke Encephalopathy/physiopathology , Female , Humans , Korsakoff Syndrome/diagnosis , Middle Aged , Treatment Outcome , Wernicke Encephalopathy/diagnosisABSTRACT
Upward and downward bias of eye movement signals in the semicircular canals (SCC)- and/or otolith-related central pathways have been proposed to explain the occurrence of vertical nystagmus (downbeat nystagmus [DBN] and upbeat nystagmus [UBN]) and its frequent modulation with head position. Video-head impulse test (VHIT), usually performed in upright position, is a recent development for measuring SCC function. We performed longitudinal nystagmus and VHIT assessments in different head positions in a patient with probable thiamine deficiency, in order to explore a possible relationship between the positional behavior of vertical nystagmus and SCC function. Initially, UBN in upright position changed to DBN in prone position and remained relatively unchanged in supine position. This was associated with both anterior and posterior SCC hyperactive responses in upright position, and a relative enhancement of the anterior SCC responses in prone position and the posterior SCC responses in supine position. Over 1 year, in prone position, change from UBN to DBN and the enhancement of anterior SCC responses remained, while in supine position, UBN either decreased or changed to DBN, when compared to upright position. This was associated with a relative enhancement of the anterior SCC responses in supine position, albeit inconsistently, and the presence of posterior SCC hypoactive responses in all positions, including prone. While not contradicting a primary otolithic dysfunction in the genesis of UBN change to DBN with head position, we provide evidence for positional modulation of SCC function in thiamine deficiency and a possible relationship with nystagmus positional behavior.
Subject(s)
Ataxia/etiology , Head Impulse Test/methods , Nystagmus, Pathologic/etiology , Thiamine Deficiency/complications , Adult , Ataxia/diagnosis , Female , Humans , Nystagmus, Pathologic/diagnosis , Nystagmus, Pathologic/physiopathology , Patient Positioning/methods , Semicircular Canals/physiopathology , Thiamine Deficiency/diagnosis , Thiamine Deficiency/physiopathology , Video RecordingSubject(s)
Alcoholism/complications , Thiamine Deficiency/drug therapy , Wernicke Encephalopathy/diagnostic imaging , Adult , Female , Humans , Magnetic Resonance Imaging , Thiamine/administration & dosage , Thiamine Deficiency/complications , Thiamine Deficiency/physiopathology , Treatment Outcome , Vitamin B Complex/administration & dosage , Wernicke Encephalopathy/drug therapy , Wernicke Encephalopathy/etiologyABSTRACT
Thiamine deficiency (TD) produces severe neurodegenerative lesions. Studies have suggested that primary neurodegenerative events are associated with both oxidative stress and inflammation. Very little is known about the downstream effects on intracellular signaling pathways involved in neuronal death. The primary aim of this work was to evaluate the modulation of p38MAPK and the expression of heme oxygenase 1 (HO-1) in the central nervous system (CNS). Behavioral, metabolic, and morphological parameters were assessed. Mice were separated into six groups: control (Cont), TD with pyrithiamine (Ptd), TD with pyrithiamine and Trolox (Ptd + Tr), TD with pyrithiamine and dimethyl sulfoxide (Ptd + Dmso), Trolox (Tr) and DMSO (Dmso) control groups and treated for 9 days. Control groups received standard feed (AIN-93M), while TD groups received thiamine deficient feed (AIN-93DT). All the groups were subjected to behavioral tests, and CNS samples were collected for cell viability, histopathology and western blot analyses. The Ptd group showed a reduction in weight gain and feed intake, as well as a reduction in locomotor, grooming, and motor coordination activities. Also, Ptd group showed a robust increase in p38MAPK phosphorylation and mild HO-1 expression in the cerebral cortex and thalamus. The Ptd group showed a decreased cell viability, hemorrhage, spongiosis, and astrocytic swelling in the thalamus. Groups treated with Trolox and DMSO displayed diminished p38MAPK phosphorylation in both the structures, as well as attenuated thalamic lesions and behavioral activities. These data suggest that p38MAPK and HO-1 are involved in the TD-induced neurodegeneration in vivo, possibly modulated by oxidative stress and neuroinflammation.
Subject(s)
Brain/metabolism , Heme Oxygenase-1/metabolism , Membrane Proteins/metabolism , Thiamine Deficiency/physiopathology , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Behavior, Animal/physiology , Body Weight/physiology , Brain/pathology , Cell Survival/physiology , Chromans/pharmacology , Dimethyl Sulfoxide/pharmacology , Eating/physiology , Inflammation/etiology , Inflammation/physiopathology , Male , Mice , Neuroprotective Agents/pharmacology , Oxidative Stress/physiology , Pyrithiamine , Thiamine Deficiency/chemically induced , Thiamine Deficiency/complications , Thiamine Deficiency/pathologyABSTRACT
BACKGROUND: Wernicke-Korsakoff Syndrome (WKS) resulting from thiamine deficiency is classically defined as including encephalopathy, ataxia, and ophthalmoplegia. Only 16% of autopsy-confirmed patients with WKS exhibit all three signs. Caine-positive WKS criteria include two or more of the following: nutritional deficiency, delirium or mild memory impairment, cerebellar dysfunction/ataxia, and oculomotor abnormalities. OBJECTIVE: We describe Caine-positive WKS prevalence among psychiatric inpatients and compare pretreatment-versus-posttreatment neurocognitive improvement to an unaffected group. METHODS: This 6-month quality-improvement evaluation included two-stage screening for Caine-positive WKS, administering high-dose intravenous thiamine (day 1: 1200 mg; days 2-4: 200 mg) with reexamination on day 5. We used descriptive statistics and fitted random effects models to examine rate-of-change differences in pre-/posttreatment Montreal Cognitive Assessment (MoCA), delayed 5-item recall, and gait/coordination scores between treated Caine-positive patients with WKS and untreated Caine-negative patients. RESULTS: Of 262 patients, 32 (12%) had Caine-positive WKS; 17 (53%) used alcohol currently. Treated Caine-positive WKS (n = 26) versus Caine-negative comparison (n = 34) before and after treatment observed a mean change (standard deviation) in the MoCA score of 3.6 (2.5) versus 1.8 (2.5) (P < 0.01); 5-item recall: 1.8 (1.4) versus 0.5 (1.4) (P < 0.001); gait/coordination scores: -0.6 (1.2) versus -0.1 (0.6) (P < 0.001). Oculomotor abnormalities were infrequent (n = 4 in Caine-positive WKS, n = 2 in Caine-negative comparison groups). CONCLUSIONS: Caine-positive WKS prevalence among psychiatric inpatients was 12%; only half used alcohol. Patients treated with high-dose thiamine demonstrated clinically significant neurocognitive improvement.
Subject(s)
Ataxia/physiopathology , Brain Diseases/physiopathology , Korsakoff Syndrome/epidemiology , Ophthalmoplegia/physiopathology , Adult , Alcoholic Korsakoff Syndrome/diagnosis , Alcoholic Korsakoff Syndrome/drug therapy , Alcoholic Korsakoff Syndrome/epidemiology , Alcoholic Korsakoff Syndrome/physiopathology , Cerebellar Diseases/physiopathology , Delirium/physiopathology , Female , Hospitalization , Humans , Korsakoff Syndrome/diagnosis , Korsakoff Syndrome/drug therapy , Korsakoff Syndrome/physiopathology , Male , Malnutrition/epidemiology , Mass Screening , Memory Disorders/physiopathology , Mental Status and Dementia Tests , Middle Aged , Ocular Motility Disorders/physiopathology , Prevalence , Thiamine/therapeutic use , Thiamine Deficiency/drug therapy , Thiamine Deficiency/physiopathology , Thinness/epidemiology , Treatment Outcome , Vitamin B Complex/therapeutic use , Weight LossABSTRACT
Thiamine metabolism dysfunction syndrome-4 (THMD4) includes episodic encephalopathy, often associated with a febrile illness, causing transient neurologic dysfunction and a slowly progressive axonal polyneuropathy. Until now only two mutations (G125S and S194P) have been reported in the SLC25A19 gene as causative for this disease and a third mutation (G177A) as related to the Amish lethal microcephaly. In this work, we describe the clinical and molecular features of a patient carrying a novel mutation (c.576G>C; Q192H) on SLC25A19 gene. Functional studies on this mutation were performed explaining the pathogenetic role of c.576G>C in affecting the translational efficiency and/or stability of hMTPPT protein instead of the mRNA expression. These findings support the pathogenetic role of Q192H (c.576G>C) mutation on SLC25A19 gene. Moreover, despite in other patients the thiamine supplementation leaded to a substantial improvement of peripheral neuropathy, our patient did not show a clinical improvement.
Subject(s)
Genetic Predisposition to Disease , Microcephaly/genetics , Mitochondrial Membrane Transport Proteins/genetics , Thiamine Deficiency/genetics , Adolescent , Brain Diseases/genetics , Brain Diseases/physiopathology , Humans , Male , Microcephaly/physiopathology , Mitochondrial Membrane Transport Proteins/chemistry , Mutation , Protein Conformation , RNA, Messenger/genetics , Thiamine/genetics , Thiamine/metabolism , Thiamine Deficiency/physiopathologyABSTRACT
Wernicke's encephalopathy (WE) is an uncommon neurological complication in pregnancies complicated with hyperemesis due to thiamine deficiency. In women with hyperemesis, inadvertent glucose administration prior to thiamine supplementation triggers the development of neurological manifestations. Delay in the diagnosis can lead to maternal morbidity, and in one-third of cases may lead to persistence of some neurological deficit. With early recognition and thiamine supplementation, complete recovery is reported. We report a case of WE complicating a case of triplet pregnancy with hyperemesis gravidarum, which highlights the importance of early recognition and treatment, resulting in complete recovery as in the index case.
Subject(s)
Escherichia coli Infections/diagnosis , Hyperemesis Gravidarum/complications , Infant, Extremely Premature , Infant, Premature, Diseases/mortality , Thiamine/therapeutic use , Wernicke Encephalopathy/diagnosis , Amikacin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Escherichia coli Infections/physiopathology , Escherichia coli Infections/therapy , Female , Fluid Therapy , Humans , Hyperemesis Gravidarum/physiopathology , Hyperemesis Gravidarum/therapy , Pregnancy , Pregnancy, Triplet , Thiamine Deficiency/physiopathology , Thiamine Deficiency/therapy , Treatment Outcome , Wernicke Encephalopathy/drug therapy , Wernicke Encephalopathy/etiology , Young AdultABSTRACT
OBJECTIVE: Thiamine deficiency (TD) is recognized in various kinds of disease with associated loss of appetite including cancer; however, TD has not been recognized in the family caregivers of cancer patients to date. METHOD: From a series of cancer patient caregivers, we reported an aged family caregiver who developed TD while caring for the cancer patient. RESULT: The caregiver was a 90-year-old male. He had been accompanying his wife, who was diagnosed with colon cancer 4 years previously, on hospital visits as the primary caregiver, but because of psychological issues, he was recommended to visit the psycho-oncology department's "caregiver's clinic" for a consultation. Detailed examination revealed that his appetite had been only about 50% of usual from about one year before, and he had lost 12 kg in weight in one year. The diagnosis of TD was supported by his abnormally low serum thiamine level. SIGNIFICANCE OF THE RESULTS: This report demonstrates that there is a possibility that care providers could develop TD from the burdens associated with caregiving. TD should be considered whenever there is a loss of appetite lasting for more than 2 weeks, and medical staff should pay careful attention to the physical condition of care providers to prevent complications resulting from TD.
Subject(s)
Caregivers/psychology , Neoplasms/psychology , Thiamine Deficiency/diagnosis , Aged, 80 and over , Delirium/blood , Delirium/etiology , Humans , Male , Neoplasms/complications , Thiamine/analysis , Thiamine/blood , Thiamine Deficiency/complications , Thiamine Deficiency/physiopathologyABSTRACT
Thiamine-responsive megaloblastic anemia (TRMA), also known as Rogers syndrome, is a rare autosomal recessive disease characterized by three main components: megaloblastic anemia, diabetes mellitus and sensorineural deafness. Those features occur in infancy but may arise during adolescence. Diagnosis relies on uncovering genetic variations (alleles) in the SLC19A2 gene, encoding for a high affinity thiamine transporter. This transporter is essentially present in hematopoietic stem cells, pancreatic beta cells and inner ear cells, explaining the clinical manifestations of the disease. Based on a multidisciplinary approach, treatment resides on lifelong thiamine oral supplementation at pharmacological doses, which reverses anemia and may delay development of diabetes. However, thiamine supplementation does not alleviate already existing hearing defects.
Subject(s)
Anemia, Megaloblastic/diagnosis , Diabetes Mellitus/diagnosis , Hearing Loss, Sensorineural/diagnosis , Membrane Transport Proteins/genetics , Thiamine Deficiency/congenital , Thiamine/therapeutic use , Anemia, Megaloblastic/physiopathology , Anemia, Megaloblastic/therapy , Diabetes Mellitus/physiopathology , Diabetes Mellitus/therapy , Diagnosis, Differential , Dietary Supplements , Hearing Loss, Sensorineural/physiopathology , Hearing Loss, Sensorineural/therapy , Humans , Mutation , Thiamine Deficiency/diagnosis , Thiamine Deficiency/physiopathology , Thiamine Deficiency/therapyABSTRACT
BACKGROUND: The previous studies have demonstrated the reduction of thiamine diphosphate is specific to Alzheimer's disease (AD) and causal factor of brain glucose hypometabolism, which is considered as a neurodegenerative index of AD and closely correlates with the degree of cognitive impairment. The reduction of thiamine diphosphate may contribute to the dysfunction of synapses and neural circuits, finally leading to cognitive decline. RESULTS: To demonstrate this hypothesis, we established abnormalities in the glucose metabolism utilizing thiamine deficiency in vitro and in vivo, and we found dramatically reduced dendrite spine density. We further detected lowered excitatory neurotransmission and impaired hippocampal long-term potentiation, which are induced by TPK RNAi in vitro. Importantly, via treatment with benfotiamine, Aß induced spines density decrease was considerably ameliorated. CONCLUSIONS: These results revealed that thiamine deficiency contributed to synaptic dysfunction which strongly related to AD pathogenesis. Our results provide new insights into pathogenesis of synaptic and neuronal dysfunction in AD.
Subject(s)
Alzheimer Disease/etiology , Alzheimer Disease/metabolism , Neurons/physiology , Synapses/physiology , Thiamine Deficiency/complications , Thiamine Deficiency/metabolism , Thiamine Pyrophosphate/deficiency , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/metabolism , Animals , Blotting, Western , Dendritic Spines/metabolism , Diphosphotransferases/metabolism , Glucose/metabolism , Hippocampus/metabolism , Hippocampus/physiopathology , Male , Mice, Inbred C57BL , Random Allocation , Rats, Sprague-Dawley , Real-Time Polymerase Chain Reaction , Synaptic Transmission/physiology , Thiamine Deficiency/physiopathology , Thiamine Pyrophosphate/metabolismABSTRACT
Thiamine is an essential cofactor for 4 enzymes involved in the production of energy (ATP) and the synthesis of essential cellular molecules. The total body stores of thiamine are relatively small, and thiamine deficiency can develop in patients secondary to inadequate nutrition, alcohol use disorders, increased urinary excretion and acute metabolic stress. Patients with sepsis are frequently thiamine deficient, and patients undergoing surgical procedures can develop thiamine deficiency. This deficiency can cause congestive heart failure, peripheral neuropathy, Wernicke's encephalopathy, Korsakoff's syndrome and gastrointestinal beriberi. In addition, thiamine deficiency can contribute to the development of intensive care unit complications, such as heart failure, delirium, critical care neuropathy, gastrointestinal dysfunction and unexplained lactic acidosis. Consequently, clinicians need to consider thiamine deficiency in patients admitted to intensive care units and the development of thiamine deficiency during the management of critically ill patients. Intravenous thiamine can correct lactic acidosis, improve cardiac function and treat delirium.
Subject(s)
Critical Illness , Postoperative Complications/etiology , Sepsis/complications , Thiamine Deficiency/physiopathology , Humans , Postoperative Complications/physiopathology , Sepsis/physiopathology , Thiamine Deficiency/etiologySubject(s)
Dietary Supplements , Heart Failure/drug therapy , Thiamine Deficiency/drug therapy , Thiamine/therapeutic use , Animals , Dietary Supplements/adverse effects , Heart Failure/diagnosis , Heart Failure/mortality , Heart Failure/physiopathology , Humans , Risk Factors , Thiamine/adverse effects , Thiamine Deficiency/diagnosis , Thiamine Deficiency/mortality , Thiamine Deficiency/physiopathology , Treatment OutcomeABSTRACT
El síndrome de realimentación es una enfermedad compleja que ocurre cuando se inicia el soporte nutricional después de un periodo de ayuno. La característica principal es la hipofosfatemia, sin embargo, también son comunes otras alteraciones bioquímicas como la hipomagnesemia, el déficit de tiamina y las alteraciones hídrico-electrolíticas. Su incidencia es desconocida, ya que no existe una definición universalmente aceptada, pero con frecuencia está infradiagnosticado. El síndrome de realimentación es un trastorno potencialmente fatal pero prevenible. Identificar a los pacientes en riesgo es crucial para mejorar su manejo. Si se diagnostica existen unas guías (NICE 2006) para orientar su tratamiento (pero basadas en un bajo grado de evidencia). Los objetivos de esta revisión son: destacar la importancia de este problema en pacientes desnutridos, discutir su fisiopatología y características clínicas y dar una serie de recomendaciones finales para disminuir el riesgo de desarrollarlo y facilitar su tratamiento
Refeeding syndrome (RS) is a complex disease that occurs when nutritional support is initiated after a period of starvation. The hallmark feature is the hypophosphataemia, however other biochemical abnormalities like hypokalaemia, hypomagnesaemia, thiamine deficiency and disorder of sodium and fluid balance are common. The incidence of RS is unknown as no universally accepted definition exists, but it is frequently underdiagnosed. RS is a potentially fatal, but preventable, disorder. The identification of patients at risk is crucial to improve their management. If RS is diagnosed, there is one guideline (NICE 2006) in place to help its treatment (but it is based on low quality of evidence). The aims of this review are: highlight the importance of this problem in malnourished patients, discuss the pathophysiology and clinical characteristics, with a final series of recommendations to reduce the risk of the syndrome and facilitate the treatment
Subject(s)
Refeeding Syndrome/complications , Hypophosphatemia/complications , Phosphorus/metabolism , Refeeding Syndrome/prevention & control , Refeeding Syndrome/physiopathology , Hypophosphatemia/etiology , Hypokalemia/complications , Magnesium Deficiency/physiopathology , Thiamine Deficiency/physiopathology , Fasting/adverse effectsABSTRACT
The WHO 2016 report indicates that worldwide obesity is rising, with over 600 million people in the obese range (BMI>30). The recommended daily calorie intake for adults is 2000 kcal and 2500 kcal for women and men respectively. The average American consumes 3770 kcal/day and the average person in the UK consumes 3400 kcal/day. With such increased caloric intake, there is an increased load on metabolic pathways, in particular glucose metabolism. Such metabolism requires micronutrients as enzyme co-factors. The recommended daily allowance (RDA) for thiamine is 1.3 mg/day and 0.5 mg thiamine is required to process 1000 kilocalories (kcal). Therefore, despite the appearance of being overfed, there is now increasing evidence that the obese population may nutritionally depleted of essential micronutrients. Thiamine deficiency has been reported to be in the region of 16-47% among patients undergoing bariatric surgery for obesity. Thiamine, in turn, requires magnesium to be in its active form thiamine diphosphate, (TDP). TDP also requires magnesium to achieve activation of TDP dependent enzymes, including transketolase (TK), pyruvate dehydrogenase (PDH) and alpha-keto glutaric acid dehydrogenase (AKGDH), during metabolism of glucose. Thiamine and magnesium therefore play a critical role in glucose metabolism and their deficiency may result in the accumulation of anaerobic metabolites including lactate due to a mismatch between caloric burden and function of thiamine dependent enzymes. It may therefore be postulated that thiamine and magnesium deficiency are under-recognized in obesity and may be important in the progress of obesity and obesity related chronic disease states. The aim of the present systematic review was to examine the role of thiamine dependent enzymes in obesity and obesity related chronic disease states.